Back To Top

June 24, 2025

Morgan Stanley Initiates Overweight Rating on Amrize Ltd with $62 Price Target

Morgan Stanley has started coverage on Amrize Ltd with an Overweight rating and a price target of $62, emphasizing their aggressive acquisition strategy and solid free cash flow prospects.

Key Highlights for Investors

  • Strong Revenue Growth: The company has achieved a 13% CAGR in revenue and a 16% CAGR in EBITDA since 2021, driven by 17 strategic acquisitions.
  • Robust Cash Flow Generation: Projected cumulative free cash flow is estimated at $7.5 billion between 2025 and 2028, facilitating future acquisitions.
  • Strong Financial Position: With a net debt to EBITDA ratio of less than 1x, Amrize has considerable financial flexibility.

Market Position and Risks

  • Market Share: Amrize is the 5th largest player in the U.S. aggregates space with a 3% share in residential roofing.
  • Acquisition Strategy: Morgan Stanley’s base case assumes 2% annual growth driven by bolt-on acquisitions.
  • Potential Upside: There is a clear upside if larger platform acquisitions accelerate growth.

Strategic Conclusion: With its low leverage profile and strong cash flow capabilities, Amrize is well-positioned for further acquisitions and EBITDA growth, justifying Morgan Stanley’s bullish Overweight stance.

Prev Post

Dow Futures Surge 400 Points Amid Ceasefire Hopes

Next Post

WazirX Secures New Hearing for User Repayment in Court

post-bars
Mail Icon

Newsletter

Get Every Weekly Update & Insights

[mc4wp_form id=]

Leave a Comment